文献速递慢阻肺

血清IgG水平与COPD住院风险:一项汇总Meta分析

Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis.
PubMed 文献 · Chest · 2020-05-19

该汇总Meta分析纳入四个COPD队列共2259例患者,评估低丙种球蛋白血症(血清IgG < 7.0 g/L)与COPD住院风险的关系。

要点

  • 低丙种球蛋白血症与COPD住院风险升高相关,汇总SHR为1.29。
  • 有既往COPD住院史者风险更高,汇总SHR为1.58。
  • 无既往住院史者风险无显著增加(SHR 1.15,95%CI 0.86-1.52)。

核心结论

  • 低丙种球蛋白血症与COPD患者住院风险升高相关,尤其在有既往住院史的患者中。

研究设计与样本

  • 汇总Meta分析,纳入四个COPD队列(MACRO n=976;STATCOPE n=653;LOTT n=354;CASCADE n=276),共2259例。
  • 基线血清IgG水平分别采用免疫散射比浊法(MACRO;STATCOPE)或质谱法(LOTT;CASCADE)测定。
  • 采用累积发生率函数(竞争风险为死亡)和Fine-Gray模型计算亚分布风险比(SHR),并进行Meta分析合并。

主要发现

  • 低丙种球蛋白血症总体频率为28.4%。
  • 低IgG组COPD住院累积发生率高于正常IgG组(Gray's检验,P < .001)。
  • 合并SHR为1.29(95%CI 1.06-1.56,P = .01)。
  • 有既往COPD住院史者(n=757)合并SHR为1.58(95%CI 1.20-2.07,P < .01)。
  • 无既往住院史者合并SHR为1.15(95%CI 0.86-1.52,P = .34)。

关键数值与推荐

  • 低丙种球蛋白血症定义为血清IgG水平 < 7.0 g/L。

临床怎么用

  • 对COPD患者,尤其有既往住院史者,可考虑检测血清IgG水平以识别住院风险较高的人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypogammaglobulinemia (serum IgG levels < 7.0 g/L) has been associated with increased risk of COPD exacerbations but has not yet been shown to predict hospitalizations. RESEARCH QUESTION: To determine the relationship between hypogammaglobulinemia and the risk of hospitalization in patients with COPD. STUDY DESIGN AND METHODS: Serum IgG levels were measured on baseline samples from four COPD cohorts (n = 2,259): Azithromycin for Prevention of AECOPD (MACRO, n = 976); Simvastatin in the Prevention of AECOPD (STATCOPE, n = 653), Long-Term Oxygen Treatment Trial (LOTT, n = 354), and COPD Activity: Serotonin Transporter, Cytokines and Depression (CASCADE, n = 276). IgG levels were determined by immunonephelometry (MACRO; STATCOPE) or mass spectrometry (LOTT; CASCADE). The effect of hypogammaglobulinemia on COPD hospitalization risk was evaluated using cumulative incidence functions for this outcome and deaths (competing risk). Fine-Gray models were performed to obtain adjusted subdistribution hazard ratios (SHR) related to IgG levels for each study and then combined using a meta-analysis. Rates of COPD hospitalizations per person-year were compared according to IgG status. RESULTS: The overall frequency of hypogammaglobulinemia was 28.4%. Higher incidence estimates of COPD hospitalizations were observed among participants with low IgG levels compared with those with normal levels (Gray's test, P < .001); pooled SHR (meta-analysis) was 1.29 (95% CI, 1.06-1.56, P = .01). Among patients with prior COPD admissions (n = 757), the pooled SHR increased to 1.58 (95% CI, 1.20-2.07, P < .01). The risk of COPD admissions, however, was similar between IgG groups in patients with no prior hospitalizations: pooled SHR = 1.15 (95% CI, 0.86-1.52, P =.34). The hypogammaglobulinemia group also showed significantly higher rates of COPD hospitalizations per person-year: 0.48 ± 2.01 vs 0.29 ± 0.83, P < .001. INTERPRETATION: Hypogammaglobulinemia is associated with a higher risk of COPD hospital admissions.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Leitao Filho FS, Mattman A, Schellenberg R, et al. Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis. Chest. 2020. PMID: 32439504. doi:10.1016/j.chest.2020.04.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。